Amendment No. 2 to Schedule 13D for LAVA Therapeutics N.V.

This Amendment No. 2 to Schedule 13D, filed by Cooperatieve Gilde Healthcare IV U.A., updates the initial filing from March 21, 2021, and Amendment No. 1 from October 14, 2025. The amendment reflects the sale of 2,298,711 common shares of LAVA Therapeutics N.V. by Gilde Healthcare between October 14, 2025, and October 17, 2025. The transactions occurred in open market sales, with detailed pricing and proceeds provided for each day. As of August 8, 2025, Gilde Healthcare held 2,947,781 common shares, representing approximately 11.2% of the outstanding shares. The amendment also includes the signatures of authorized persons and details of the reporting persons.